A new nanomedicine based on didanosine glycerolipidic prodrug enhances the long term accumulation of drug in a HIV sanctuary - Bertin Instruments

    Scientific publications

    A new nanomedicine based on didanosine glycerolipidic prodrug enhances the long term accumulation of drug in a HIV sanctuary

    Rym Skanjia, Karine Andrieuxa, , , Muriel Lalannea, Joachim Caronb, Claudie Bourgauxa, Jéril Degrouardc, François Brissetd, Claire Gueutina, Hélène Chacuna, Nathalie Dereuddre-Bosquete, Angelo Pacif, Gilles Vassalf, Laurent Bauduing, Sébastien Garcia-Argoteh, Bernard Rousseauh, Pascal Clayettee, Didier Desmaëleb, Patrick Couvreura
    Sources: a Univ Paris Sud, CNRS, UMR 8612, IFR 141, F-92296 Châtenay-Malabry, France b CNRS, Univ Paris Sud, UMR 8076, IFR 141, F-92296 Châtenay-Malabry, France c CNRS, Univ Paris Sud, UMR 8502, LPS, F-91400 Orsay, France d CNRS, Univ Paris Sud, UMR 8182, ICMMO, F-91400 Orsay, France e Bertin Pharma, Laboratoire de Neurovirologie, CEA, F-92265 Fontenay aux Roses, France f Univ Paris Sud, UPRES EA Life SciencesLife Sciences, IFR 54, F-94805 Villejuif, France g Bertin Pharma, Laboratoire de bioanalyses, CEA, F-91191 Gif-sur-Yvette, France h CEA/Saclay, Department of Radiolabeled Molecules, F-91191 Gif-sur-Yvette, France
    International Journal of PharmaceuticsVolume 414, Issues 1-2, 29 July 2011, Pages 285-297 doi:10.1016/j.ijpharm.2011.05.005

    Sample name

    Animal tissues

    ANY QUESTIONS? CONTACT AN EXPERT

    Please fill in this form if you wish to contact our sales team or receive further information.

    My Account
    Forgot password ?

    Add a question !

    Add a question